192 related articles for article (PubMed ID: 19138659)
1. The X-ray structure of ricin A chain with a novel inhibitor.
Bai Y; Monzingo AF; Robertus JD
Arch Biochem Biophys; 2009 Mar; 483(1):23-8. PubMed ID: 19138659
[TBL] [Abstract][Full Text] [Related]
2. Structure-based identification of a ricin inhibitor.
Yan X; Hollis T; Svinth M; Day P; Monzingo AF; Milne GW; Robertus JD
J Mol Biol; 1997 Mar; 266(5):1043-9. PubMed ID: 9086280
[TBL] [Abstract][Full Text] [Related]
3. Structure-based design and characterization of novel platforms for ricin and shiga toxin inhibition.
Miller DJ; Ravikumar K; Shen H; Suh JK; Kerwin SM; Robertus JD
J Med Chem; 2002 Jan; 45(1):90-8. PubMed ID: 11754581
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of ricin A-chain with pyrrolidine mimics of the oxacarbenium ion transition state.
Roday S; Amukele T; Evans GB; Tyler PC; Furneaux RH; Schramm VL
Biochemistry; 2004 May; 43(17):4923-33. PubMed ID: 15109250
[TBL] [Abstract][Full Text] [Related]
5. 7-Substituted pterins provide a new direction for ricin A chain inhibitors.
Pruet JM; Jasheway KR; Manzano LA; Bai Y; Anslyn EV; Robertus JD
Eur J Med Chem; 2011 Sep; 46(9):3608-15. PubMed ID: 21641093
[TBL] [Abstract][Full Text] [Related]
6. Differences in cytotoxicity of native and engineered RIPs can be used to assess their ability to reach the cytoplasm.
Svinth M; Steighardt J; Hernandez R; Suh JK; Kelly C; Day P; Lord M; Girbes T; Robertus JD
Biochem Biophys Res Commun; 1998 Aug; 249(3):637-42. PubMed ID: 9731188
[TBL] [Abstract][Full Text] [Related]
7. Structure and activity of an active site substitution of ricin A chain.
Day PJ; Ernst SR; Frankel AE; Monzingo AF; Pascal JM; Molina-Svinth MC; Robertus JD
Biochemistry; 1996 Aug; 35(34):11098-103. PubMed ID: 8780513
[TBL] [Abstract][Full Text] [Related]
8. Structure-based design of ricin inhibitors.
Jasheway K; Pruet J; Anslyn EV; Robertus JD
Toxins (Basel); 2011 Oct; 3(10):1233-48. PubMed ID: 22069693
[TBL] [Abstract][Full Text] [Related]
9. Structural analysis of ricin and implications for inhibitor design.
Robertus JD; Yan X; Ernst S; Monzingo A; Worley S; Day P; Hollis T; Svinth M
Toxicon; 1996; 34(11-12):1325-34. PubMed ID: 9027989
[TBL] [Abstract][Full Text] [Related]
10. Structure of ricin A-chain at 2.5 A.
Katzin BJ; Collins EJ; Robertus JD
Proteins; 1991; 10(3):251-9. PubMed ID: 1881881
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of ricin toxin A chain complexed with a highly potent pterin-based small-molecular inhibitor.
Goto M; Sakamoto N; Higashi S; Kawata R; Nagatsu K; Saito R
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2219038. PubMed ID: 37259593
[TBL] [Abstract][Full Text] [Related]
12. The structure and action of ricin, a cytotoxic N-glycosidase.
Robertus J
Semin Cell Biol; 1991 Feb; 2(1):23-30. PubMed ID: 1954340
[TBL] [Abstract][Full Text] [Related]
13. A novel designed single domain antibody on 3-D structure of ricin A chain remarkably blocked ricin-induced cytotoxicity.
Shuntao W; Jiannan F; Jianwei G; Leiming G; Yan L; Yingxun S; Weisong Q; Meiru H; Gencheng H; Beifen S
Mol Immunol; 2006 Apr; 43(11):1912-9. PubMed ID: 16343623
[TBL] [Abstract][Full Text] [Related]
14. Peptide-conjugated pterins as inhibitors of ricin toxin A.
Saito R; Pruet JM; Manzano LA; Jasheway K; Monzingo AF; Wiget PA; Kamat I; Anslyn EV; Robertus JD
J Med Chem; 2013 Jan; 56(1):320-9. PubMed ID: 23214944
[TBL] [Abstract][Full Text] [Related]
15. Ricin A-chain substrate specificity in RNA, DNA, and hybrid stem-loop structures.
Amukele TK; Schramm VL
Biochemistry; 2004 May; 43(17):4913-22. PubMed ID: 15109249
[TBL] [Abstract][Full Text] [Related]
16. Pterin-based small molecule inhibitor capable of binding to the secondary pocket in the active site of ricin-toxin A chain.
Saito R; Goto M; Katakura S; Ohba T; Kawata R; Nagatsu K; Higashi S; Kurisu K; Matsumoto K; Ohtsuka K
PLoS One; 2022; 17(12):e0277770. PubMed ID: 36508422
[TBL] [Abstract][Full Text] [Related]
17. Degradation of ricin A chain by endosomal and lysosomal enzymes--the protective role of ricin B chain.
Bilge A; Howell-Clark J; Ramakrishnan S; Press OW
Ther Immunol; 1994 Aug; 1(4):197-204. PubMed ID: 7584495
[TBL] [Abstract][Full Text] [Related]
18. The isolation and characterization of temperature-dependent ricin A chain molecules in Saccharomyces cerevisiae.
Allen SC; Moore KA; Marsden CJ; Fülöp V; Moffat KG; Lord JM; Ladds G; Roberts LM
FEBS J; 2007 Nov; 274(21):5586-99. PubMed ID: 17916187
[TBL] [Abstract][Full Text] [Related]
19. Development of N-2,4-pyrimidine-N-phenyl-N'-alkyl ureas as orally active inhibitors of tumor necrosis factor alpha (TNF-alpha) synthesis. Part 2.
Maier JA; Brugel TA; Clark MP; Sabat M; Golebiowski A; Bookland RG; Laufersweiler MJ; Laughlin SK; Vanrens JC; De B; Hsieh LC; Brown KK; Juergens K; Walter RL; Janusz MJ
Bioorg Med Chem Lett; 2006 Jul; 16(13):3514-8. PubMed ID: 16632350
[TBL] [Abstract][Full Text] [Related]
20. Development of N-2,4-pyrimidine-N-phenyl-N'-phenyl ureas as inhibitors of tumor necrosis factor alpha (TNF-alpha) synthesis. Part 1.
Brugel TA; Maier JA; Clark MP; Sabat M; Golebiowski A; Bookland RG; Laufersweiler MJ; Laughlin SK; Vanrens JC; De B; Hsieh LC; Mekel MJ; Janusz MJ
Bioorg Med Chem Lett; 2006 Jul; 16(13):3510-3. PubMed ID: 16632356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
